NextCure, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 6.31 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 28.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company’s product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer’s disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Baltimore, Maryland.
Details
| Name | NextCure, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 40 |
| Founded | 2015 |
| Ipo Date | 2019-05-09 |
| Ceo | Michael Richman |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 15.00 |
| Isin | US65343E2072 |
| Cusip | 65343E207 |
| Cik | 1661059 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Michael S. Richman MSBA | Co-Founder, Chief Executive Officer, President and Director |
| Dr. Timothy Mayer Ph.D. | Chief Operating Officer |
| Dr. Udayan Guha M.D., Ph.D. | Chief Medical Officer |
| Dr. Lieping Chen M.D., Ph.D. | Co-Founder and Chairman of Scientific Advisory Board |
| Steven P. Cobourn CPA | Chief Financial Officer |
| Kevin G. Shaw | Senior Vice President and General Counsel |
| Sourav Kundu Ph.D. | Senior Vice President of Development and Manufacturing |
| Dr. Sebastien Maloveste Ph.D. | Senior Vice President of Business Development |
Contact
| Address | 2850 Quarry Lake Drive, Suite 280, Baltimore, Maryland 21209, United States |
| Phone | 240 399 4900 |
| Website | https://www.nextcure.com |